Resistance to detachment-induced apoptosis, a process commonly referred as anoikis, is emerging as a hallmark of metastatic malignancies, mainly because it can ensure anchorage-independent growth and survival during organ colonization. Besides, a sustained oxidative stress has been associated with several steps of carcinogenesis, including transformation and achievement of a motile mesenchymal phenotype. Here, we demonstrate that metastatic prostate carcinoma cells, undergoing a constitutive deregulated production of reactive oxygen species due to sustained activation of 5-lipoxygenase, lack suicidal pathways in response to lack of matrix contact. These amplified and persistent redox signals in PC3 cells leads to maintenance of Src oxidation and activation in the absence of adhesion, thereby sustaining a ligand-independent phosphorylation of epidermal growth factor receptor. This leads to chronic activation of pro-survival signals, culminating in degradation of the pro-apoptotic protein Bim, thereby promoting cell survival even in the absence of proper adhesion. Anoikis sensitivity of metastatic cells is restored with antioxidant intervention or genetic manipulation of the redox-mediated pro-survival pathway, as well as exposure to a pro-oxidant environment strongly increases anoikis resistance in nontransformed prostate epithelial cells. Hence, our results allow new insight into the aetiology of the molecular mechanisms granting anoikis resistance of metastatic cancers, opening new avenues to pharmacological intervention for antioxidant-sensitive invasive tumours.
Introduction
Most normal epithelial and endothelial cells require adhesion to a specific type of extracellular matrix (ECM) to survive. On detachment of cells from its supportive matrix, they undergo a particular type of apoptosis, widely known as anoikis (Frisch and Screaton, 2001 ). This process is important for maintaining tissue homoeostasis and plays an essential role in the prevention of dissemination of cells to inappropriate sites, most notably during the metastatic process (Valentijn et al., 2004; Reddig and Juliano, 2005) . Resistance to anoikis is thus emerging as a hallmark of metastatic cancer cells, mainly because anchorageindependent growth of tumour cells is a classic feature of different types of human malignancies (Frisch and Screaton, 2001; Zhu et al., 2001) . The underlying mechanisms granting cancer cells to evade anoikis are not fully understood, but it has been suggested that stimulation of pro-survival signals and inhibition of apoptotic pathways may be involved.
BH3-only proteins, counting Bid, Bad, Bim, Bik, Bmf, Noxa, are essential players during anoikis execution (Bouillet and Strasser, 2002) . In particular, following cell detachment from ECM, Bim translocates to mitochondria and rapidly interacts with Bcl-XL, thus neutralizing its pro-survival function and promoting Bax activation (Reginato et al., 2003) . Integrin engagement and/or growth factor stimulation promote extracellular signal-regulated protein kinases (ERKs) and phosphatidylinositol 3-kinase (PI3K)/Akt-mediated phosphorylation of Bim, culminating in its proteasome-dependent degradation (Le Gall et al., 2000; Qi et al., 2006) . Upon loss of ECM contact, inhibition of ERK and PI3K/Akt signalling converging on Bim phosphorylation, leads to the abolishment of its degradation and finally to its accumulation. In nontransformed epithelial cells protection from anoikis is granted by a pro-survival signal elicited by the integrindependent and ligand-independent epidermal growth factor receptor (EGFR) activation. Reactive oxygen species (ROS), produced through the involvement of the small GTPase Rac-1 upon integrin engagement, are key players in transducing this pro-survival signal ensuring escapement from anoikis. ROS are responsible for direct oxidation of the tyrosine kinase Src, thereby leading to its activation. The activated kinase in turn elicits a ligand-independent trans-phosphorylation of EGFR, that sequentially switches both ERK and Akt pathways, culminating in Bim degradation (Giannoni et al., 2008) .
Although low and transient levels of ROS regulate cellular signalling and play an important role in normal cell proliferation and adhesion, it is now accepted that ROS production is constitutively increased in several cancer cells (Szatrowski and Nathan, 1991) . The sustained ROS generation interferes with the expression of a number of genes and signal transduction pathways, such as cell cycle regulation, proliferation, tumour invasion and angiogenesis. The high oxidative milieu is thus instrumental in the process of carcinogenesis (Valko et al., 2007) . We therefore speculate that the cancer-related redox imbalance may release amplified and deregulated signals which are normally triggered by integrin engagement in a transient fashion, thus leading to sustained anchorage-related signals granting for anchorage-independent survival. We chose a model of human metastatic carcinoma, undergoing a constitutive oxidative stress due to deregulated oxidant production, lacking suicidal pathways in response to lack of ECM adhesion. In metastatic cells the oxidized/activated Src leads to a sustained activation of EGFR-related prosurvival signals and inhibition of the apoptotic machinery. We addressed the question of whether intervention with antioxidants or genetic manipulation of the molecular targets of this oxidative stress, that is, the small GTPase Rac1 or the kinases EGFR and Src, may affect anoikis resistance of metastatic cells.
Results

Prostate metastatic cells exhibit high amount of intracellular ROS and escape from detachmentinduced apoptosis
We previously reported that in adherent non-transformed cells ROS, produced through the involvement of the small GTPase Rac-1 upon integrin engagement, exert a mandatory role in transducing a pro-survival signal ensuring cells to escape from anoikis (Giannoni et al., 2008) . Moreover, ROS are constitutively increased in several tumour cells (Szatrowski and Nathan, 1991; Haklar et al., 2001) . We speculate that constitutive high ROS production in cancer cells may correlate with their resistance to anoikis commitment. We first compared four human prostate-derived cell lines that include normal prostate epithelial cells (RWPE-1) and three prostate carcinoma cells with increasing aggressive properties, that is, LNCaP, DU145 and PC3 cells (Pulukuri et al., 2005) . As shown in Figures 1a and b , among all the tested cell lines PC3 cells possess higher intracellular ROS content and are the most skilled to escape anoikis. We therefore selected PC3 as the most RWPE-1, LNCaP, DU145 or PC3 cells were serum-starved for 24 h and the ROS intracellular content was evaluated by means of 2 0 ,7 0 -dichlorodihydrofluorecein diacetate labelling. Data have been normalized on total protein content. *Po0.001 versus RWPE-1 and LNCaP and Po0.05 versus DU145. (b) 1 Â 10 6 RWPE-1, LNCaP, DU145 or PC3 cells were serum-starved for 24 h, detached and maintained in serum-free medium for additional 24 h. The percentage of apoptotic cells was evaluated by means of an Annexin V/PI labelling followed by a cytofluorimetric analysis. *Po0.001 versus RWPE-1 and LNCaP and Po0.05 versus DU145. (c) PC3 (1 Â 10 6 ) or RWPE-1 cells were serum-starved for 24 h, then detached, maintained in serum-free medium for 30 min and then kept in suspension or seeded onto fibronectin-coated dishes for the indicated times. ROS intracellular content was evaluated by means of 2 0 ,7 0 -dichlorodihydrofluorecein diacetate labelling. Data have been normalized on total protein content. *Po0.001 and Oxidants confer anoikis resistance to cancer cells E Giannoni et al suitable model of prostate carcinoma cells for our further studies. First, we analysed ROS content in PC3 prostate metastatic carcinoma cells and in non-transformed prostate epithelial RWPE-1 cells, during detachment from ECM. ROS evaluation shows that RWPE-1 exhibit a transient production of ROS after 10 min from cell detachment and upon 30 min of integrin engagement. Conversely, PC3 carcinoma cells constitutively display higher amounts of intracellular ROS, which remains insensitive to ECM contact (Figure 1a) . To assess whether the amount of intracellular ROS in resting condition could account for cell susceptibility to detachment-induced anoikis, we evaluated anoikis commitment upon suspension. RWPE-1 shows a transient and brief protection from anoikis, but they are irreversibly committed to apoptosis after 3 h of cell suspension. On the contrary, PC3 cells show a strong and long-term resistance to anoikis following detachment from ECM ( Figure 1b ).
Src tyrosine kinase is constitutively oxidized and activated in prostate cancer cells Intracellular ROS produced after integrin stimulation and/or growth factor administration act on several targets, among which are protein tyrosine phosphatases, protein tyrosine kinases, cytoskeletal proteins and transcription factors (Chiarugi and Fiaschi, 2007) . In a recent paper, we provided evidence that c-Src is one of the main targets of integrin-elicited ROS and that Src oxidation, that involves two cysteine residues (C245 and C487), leads to a strong enhancement of Src activity (Giannoni et al., 2005) . This redox upregulation of Src kinase has been involved in the integrin-mediated suppression of anoikis in anchorage-dependent epithelial cells (Giannoni et al., 2008) . Therefore, we evaluated Src redox state through labelling with N-(biotinoyl)-N 0 -(iodoacetyl) ethylenediamine, a sulfhydryl-modifying reagent that selectively probes the thiolate form of reduced cysteines. The phosphorylation of Src Tyr416 was also analysed, to assess the activation of the kinase. We observed that in RWPE-1 cells Src is transiently oxidized/activated after cell detachment, but gradually recovers its reduced/inactive state, during persistent lack of proper ECM attachment (Figures 2a and b) . In agreement with these findings, Loza-Coll et al. (2005) , reported that after detachment of intestinal epithelial cells there is a transient increase in Src activity, which contributes to the transient protection from anoikis . In keeping with our previous observation in non-transformed cells (Giannoni et al., 2005) , when RWPE-1 suspended cells are allowed to re-adhere on ECM, the ROS burst produced upon integrin engagement accounts for the strong oxidation and activation of the kinase. Conversely, in metastatic PC3 cells Src is continuously oxidized/activated during both suspension and ECM adhesion, likely accounting for their resistance to detachment-induced apoptosis (Figures 2a and  b) . Interestingly, PC3 are the prostate-derived carcinoma cells that show the higher levels of constitutive oxidation and activation of the Src kinase with respect to other prostate cancer cells, for example, LNCaP and DU145, in accordance with their higher aggressiveness and metastatic potential (Pulukuri et al., 2005) (Supplementary Figure S1 ). This observation suggests a possible correlation between Src redox state/activity and the malignant properties of human prostate cancer cells.
Src activation promotes EGFR phosphorylation leading to protection from apoptosis
The strict collaboration between integrin-and growth factor-signalling in the control of cell growth, survival and migration is now widely established (Comoglio et al., 2003) . In epithelial cells integrin engagement triggers a ligand-independent EGFR phosphorylation on Tyr845 that induces a proper transcriptional response accounting for the achievement of full biological responses (Cabodi et al., 2004) . This EGFR phosphorylation leads to the activation of downstreamsignalling pathways sufficient to protect cells from apoptosis (Moro et al., 1998) . Recently, we reported that ROS produced on integrin engagement induces an Src-dependent, ligand-independent activation of EGFR, which culminates in the degradation of the proapoptotic protein Bim, hence accounting for the redox control of the integrin-mediated protection from anoikis (Giannoni et al., 2008) . On the basis of this evidence, we analysed the activation of EGFR in both RWPE-1 and PC3 cells. In RWPE-1 cells Src, in its Tyr416-phosphorylated/activated form, associates and phosphorylates EGFR on Tyr845 during the first minutes after cell detachment, as well as during re-adhesion (Figures 3a and b) . The early and transient Srcdependent activation of EGFR assures a protection from anoikis for about 3-4 h. Thereafter, the ligand- Oxidants confer anoikis resistance to cancer cells E Giannoni et al independent EGFR phosphorylation disappears and suspended RWPE-1 cells are forced to die ( Figure 1b) . Conversely, in PC3 cells activated Src is constitutively associated to EGFR both in suspended and adherent conditions ( Figure 3a ). This allows for a constitutive ligand-independent phosphorylation of EGFR (Figure 3b ), which may explain the anoikis insensitivity of these cells.
Compelling evidence indicate a crucial role of both ERK-and Akt-signalling pathways in conferring cell resistance to anoikis (Zeng et al., 2002) . As expected, the pro-survival downstream signalling elicited by EGFR, namely ERKs and Akt pathways, are just transiently activated in RWPE-1 suspended cells and return to their inactive state in a few hours (Figures 3c and d) . On the contrary, PC3 cells exhibit a constitutive activation of both ERKs and Akt, at the same extent in suspended or adherent conditions (Figures 3c and d) . Both activated ERKs and Akt phosphorylate the BimEL isoform of the BH3-only protein Bim, thus promoting its ubiquitinmediated degradation and thereby blocking its proapoptotic activity (Le Gall et al., 2000; Ley et al., 2005; Qi et al., 2006) . Therefore, we analysed the amount of Bim in RWPE-1 and PC3 cells upon cell detachment. In keeping with the above results, we observed that in RWPE-1 Bim is not detectable in the first minutes after cell/ECM contact disruption, when ERKs and Akt actively transduce a pro-survival signal, but strongly increases later, reaching a maximum expression in concomitance with ERK and Akt downregulation ( Figure 3e ). On the other hand, in PC3 cells we do not observe any detectable level of Bim in both suspended and adherent cells, confirming their ability to actively fight against apoptosis onset ( Figure 3e ). Altogether our results show that metastatic carcinoma cells exhibit a constitutive ligand-independent activation of EGFR and of its downstream pro-survival signals, likely accounting for the inhibition of the apoptotic process.
Rescue of PC3 cell anoikis resistance by antioxidants and Src and Rac mutants We speculate that the constitutive oxidative milieu may be responsible for conferring to metastatic carcinoma cells the ability to evade anoikis. To assess this hypothesis, we evaluate apoptosis commitment of PC3 cells upon cell suspension in the presence or absence of N-acetyl cisteine (NAC), a general ROS scavenger. As shown in Figure 4a , antioxidant administration restores detachment-induced anoikis in PC3 cells. Of note, the concomitant treatment of pre-adherent PC3 cells with NAC excludes a toxic effect of this drug at our working concentration and also suggests that the ROS-mediated protective effect is specific to anoikis and does not affect apoptosis of attached cells. Interestingly, NACmediated ROS removal is effective in making the PC3 intracellular levels of H 2 O 2 similar to those of RWPE-1 cells (Supplementary Figure S2) as well as in turning PC3 cells towards a phenotype comparable with the anoikis-sensitive RWPE-1 cells (Figure 4b ). In addition, the NAC-mediated ROS depletion quite completely abolishes Src activation and EGFR phosphorylation (Figure 4c ). We therefore evaluate the activity of the pro-apoptotic machinery, by analysing Bad phosphorylation level and Bim expression. As shown in Figure 4c , antioxidant administration prevents the phosphorylation of the BH3-only protein Bad, which in the dephosporylated state binds Bcl-xL, thus abrogating its anti-apoptotic function. A latere, we observed that or RWPE-1 cells were serum-starved for 24 h, then detached, maintained in serum-free medium for 30 min and then kept in suspension or seeded onto fibronectin-coated dishes for the indicated times. Src association with EGFR was evaluated by an anti-Src (total Src) or anti-pY416Src (active Src) immunoblots performed on anti-EGFR immunoprecipitates (a), whereas EGFR tyrosine phosphorylation on Tyr 845 was evaluated by specific anti-pTyr845 immunoblot performed on anti-EGFR immunoprecipitates (b). An anti-EGFR immunoblot was used to normalize. (c-d) PC3 and RWPE-1 cells were treated as in panel a. Cell lysates from each sample were used to detect the phosphorylation level of ERKs (c) and Akt (d), with the correspondent phospho-specific antibodies. Anti-ERK and anti-Akt immunoblots were performed for normalization. (e) Cells were treated as in panel a, except that cells lysates were used to detect Bim level (an anti-actin immunoblot was used as a loading control). All data are representative of at least three independent experiments.
Oxidants confer anoikis resistance to cancer cells E Giannoni et al NAC also prevents Bim degradation, thus allowing its accumulation (Figure 4d ).
The role of ROS in conferring PC3 anoikis resistance was further confirmed by the genetic modulation of ROS content, through the overexpression of the dominant-negative Rac-1 mutant (RacN17). This small GTPase is a widely acknowledged upstream regulator of ROS production (Sundaresan et al., 1996; Irani and Goldschmidt-Clermont, 1998) . As shown in Figure 5a , anoikis resistance of PC3 was almost completely reverted in RacN17-overexpressing cells. Interestingly, reduction of ROS through RacN17 overexpression specifically reverse PC3 anoikis resistance and does not induce apoptosis of attached cells. Therefore, RacN17-mediated ROS reduction in suspended cells is accompanied by the inhibition of Src activation and EGFR phosphorylation (Figure 5b ) and by the activation of the pro-apoptotic pathways, namely Bad dephosphorylation and Bim accumulation (Figure 5c ).
To establish the role of Src oxidation in ensuring anoikis protection of metastatic carcinoma cells, PC3 cells were transfected with the redox-insensitive mutants SrcC245A and SrcC487A. The cytofluorimetric analysis reveals a rescue of anoikis sensitivity of PC3 cells overexpressing Src mutants, without inducing apoptotic cell death on adherent cells (Figure 6a ). This correlates with the inhibition of Src activity and downregulation of EGFR ligand-independent phosphorylation ( Figure 6b ) and with the activation of the apoptotic machinery (Figure 6c ).
Although EGFR activation is broadly recognized as a pro-survival signal for several cancer cells (Le Gall et al., 2000) , we further confirm the key role of its constitutive activation for prostate metastatic cells. Indeed, we analysed anoikis sensitivity of adherent and suspended PC3 cells during treatment with the selective EGFR inhibitor AG1478. The results reveal that EGFR inhibition (Figure 7a ) strongly impairs the ability of metastatic cells to overcome anoikis, as indicated by the Annexin V/PI staining ( Figure 7b ) and the analysis of the apoptotic markers Bad and Bim (Figure 7c ).
Taken together, these data indicate that the protection from anoikis of metastatic carcinoma cells is granted by a redox-mediated pathway involving as key players the small GTPase Rac-1, the kinase Src and the EGFR. Oxidants
5-LOX activation is involved in anoikis resistance of PC3 cells
To characterize the oxidants responsible for the generation of the pro-oxidative environment in metastatic carcinoma cells, PC3 cells were treated with selective inhibitors of intracellular sources of ROS. In addition to the general scavenger NAC, we used diphenyl-iodide to block NADPH oxidase, nordihydroguaiaretic acid or AA861 to block 5-LOX and rotenone to inhibit mitochondrial ROS release. The results of anoikis sensitivity exclude a significant involvement of both NADPH oxidase and mitochondrial respiratory chain and indicate a major involvement of 5-LOX, based on the main effectiveness of nordihydroguaiaretic acid and AA861 to impair cell survival (Figure 8a ). On the contrary, the treatment of attached cells with the above mentioned ROS inhibitors does not induce an impairment of cell survival, suggesting a specific role of ROS in ensuring anoikis resistance (Figure 8a and Supplementary Figure S3 ). To confirm the role of 5-LOX in mediating the ROS-dependent protection from anoikis, we use a short Interfering RNA (siRNA)-based phenotypic-silencing approach. We have initially verified that 72 h after siRNA transfection the expression of 5-LOX is almost undetectable (Figure 8c , lower panel). As shown in Figures 8b and c , 5-LOX-silenced PC3 cells exhibit a downregulation of ROS intracellular content ( Figure 8b ) and a subsequent significant increase of apoptotic cells, which is observed in suspension but not in pre-adherent cells (Figure 8c) . Furthermore, the Src activation level and the ligand-independent tyrosine phosphorylation of EGFR are greatly affected by 5-LOX silencing, resulting in the accumulation of the pro-apoptotic BH3-only protein Bim (Figure 8d ). Altogether, our data suggest that 5-LOX is mainly responsible for the activation of the redox-mediated protective signals that ensure PC3 cells to overcome the anoikis programme.
Induction of anoikis resistance upon exogenous oxidative stress Our observations indicate that the protection from anoikis of metastatic cells can be efficiently rescued by interruption of the constitutive oxidative stress signals.
In an opposite fashion, our hypothesis is that exposure to a pro-oxidant environment could 'fill the gap' and mimic the redox signalling induced by integrin-mediated cell adhesion, allowing untransformed prostate epithelial cells to escape from anoikis. Indeed, the exogenous addition of physiological doses of H 2 O 2 , similar to that transiently generated during adhesion-induced integrin activation (Sundaresan et al., 1996; Chiarugi et al., Oxidants confer anoikis resistance to cancer cells E Giannoni et al (Figure 9a ). Accordingly with a pro-survival-activated signal, in suspended RWPE-1 cells we also observed activation of the Src kinase, the appearance of EGFR phosphorylation and the inhibition of the pro-apoptotic markers, that is, Bad phosphorylation and Bim degradation (Figure 9b ).
2003), protects RWPE-1 cells from anoikis
Altogether our data underline the crucial role of ROS in ensuring anoikis resistance, because on one hand their removal abrogates PC3 insensitivity to detachmentinduced apoptosis and, on the other hand, exposure to a pro-oxidant environment allows normal epithelial cells to receive protection from anoikis and to survive while being detached.
Discussion
The results presented in this report lead to three major conclusions: (i) prostate metastatic cells lacking suicidal pathways in response to loss of ECM contact avoid anoikis through a redox-mediated pathway; (ii) in these cells the production of ROS independent from ECM contact leads to a constitutive and redox-mediated activation of a pro-survival pathway which, through an Src kinase-dependent sustained EGFR activation guides degradation of pro-apoptotic proteins and (iii) disruption of this pro-survival pathway restores in metastatic cells the sensitivity to anoikis.
The process, which selects invasive cancer cells requires that some cells belonging to the primary tumour successfully complete several sequential steps affecting their ability to survive, move and colonize new organs. Metastasizing cancer cells must detach from the primary tumour, invade the stroma microenvironment, enter lymphatic or blood vessels, spread to distant/ different organs, again cross the endothelial barrier and extravasate and finally grow in the target organ parenchyma (Chambers et al., 2002) . A successful metastatic cell has therefore bypassed the proliferative, survival, migratory and invasive barriers and developed novel adjustment abilities, including alteration of cellcell and cell-ECM adhesions, the independence from the anoikis programme, as well as deregulated growth, adhesive and motile factor signalling (Kopfstein and Christofori, 2006) .
Although the involvement of ROS as pro-carcinogenic agents has been strongly supported by the past literature (Szatrowski and Nathan, 1991; Toyokuni, 2006) , their role in the acquisition of an invasive and metastatizing phenotype is still not completely understood. The state of the art strongly implicates ROS, and in particular hydrogen peroxide and the superoxide anion radical, in cell adhesion (Chiarugi et al., 2003 ; Chiarugi and Fiaschi, 2007; Taddei et al., 2007) , motility (Moldovan et al., 2006; Wu et al., 2008) , cell transformation by oncogenes as Ras or Bcr-Abl (Wu, 2006) , regulation of proteolytic degradation of ECM by matrix metalloproteinases (Nelson and Melendez, 2004) , as well as in the acquisition of an invasive phenotype through epithelial-to-mesenchimal transition (Radisky et al., 2005; Cannito et al., 2008) . Our present data enlarge the horizon for redox cancer biology and propose these oxidant molecules as central players in another key point for metastatic cells allowing them to spread metastases to distant organs, that is, the resistance to anoikis. Indeed, in our prostate metastatic model, ROS grants to the metastatic cells the possibility to escape the natural programmed cell death upon loss of ECM contact and to protract their survival.
Our comparative analysis on prostate carcinoma cells indicate a strong correlation between constitutive ROS production and their different potential for aggressiveness (Pulukuri et al., 2005) . This finding is in agreement with a plethora of data describing cancer cell undergoing a constitutive oxidative stress. More originally, these ROS are not sensitive to ECM contact. In nontransformed cells integrin ligation gives rise to a strong but transient ROS burst which has been causally linked to the regulation of several phenomena, including Src kinase and focal adhesion kinase activation, Rho inhibition through p190RhoGAP dephosphorylation, as well as actin polymerization. In PC3 cells the production of ROS is fully independent from integrin ligation and ECM contact, suggesting the existence of ECM-independent mechanisms to grant activation of downstream pathways. Indeed, these cells do not accumulate the pro-apoptotic protein Bim in response to ECM detachment, showing to lack suicidal pathways and to be able to escape from detachment-induced apoptosis. In agreement, these cells show constitutive activation of Akt and ERKs, likely accounting for the degradation of Bim and elimination of apoptogenic stimuli. The role of Akt and ERK signalling in elimination of Bim has been already reported (Ley et al., 2005; Qi et al., 2006) . In agreement with our data both ERK and Akt have already been involved in the inhibition of anoikis (Zeng et al., 2002; Kairouz-Wahbe et al., 2008) . The pro-survival signal sustaining anoikis resistance of prostate cancer cells is guaranteed by sustained Src kinase activation, thereby leading to a persistent but ligand-independent activation of EGFR. Activation of both Src and EGFR kinases is not a novel theme of cancer biology and the two kinases have been involved also in anoikis resistance. Indeed, several recent reports describe the key role of EGFR-dependent protection from anoikis in lung fibroblasts (Le Gall et al., 2000) , in mammary epithelial cells or epidermal keratinocytes (Quadros et al., 2004) . Besides, the kinase Src has been causally linked to transient protection from apoptosis during both integrin engagement (Moro et al., 1998; Diaz-Montero et al., 2006; Giannoni et al., 2008) , as well as during initial detachment of epithelial cells from basal membrane (Loza-Coll et al., 2005) . In addition, in human lung adenocarcinoma cells, Src activation compensates for the loss of cell survival signals caused by disruption of cell-ECM interactions and contributes to anoikis resistance (Wei et al., 2004) . Our finding contributes to this pro-survival circuitry with the novel proposal that the specific role of Src activity during protection from anoikis is mainly redoxbased and that ROS are central players of the sustained activation of the kinase in PC3 cells. Indeed we observed that the elimination of Src redox regulation, through transfection of redox-insensitive Src mutants, or elimination of constitutive sources of these oxidants, give rise to a rescue of the apoptotic phenotype in response ) or RWPE-1 cells were serum-starved for 24 h, then detached and maintained in serum-free medium for 30 min with or without 10 mM AG1478. Cells were then kept in suspension or seeded onto fibronectincoated dishes for 24 h. EGFR tyrosine phosphorylation was evaluated by probing with anti-pTyr845-specific antibodies and normalized with an anti-EGFR immunoblot. (b) PC3 cells were treated as in panel a, except that apoptotic cells, pre-treated or not with AG1478, were evaluated by means of an Annexin V/PI labelling followed by a cytofluorimetric analysis. *Po0.001 versus 24 h adherent cells ('Adh.24 h'). (c) PC3 cells, treated as in panel a, were lysed and a western blot analysis was performed to evaluate Bad phosphorylation (an anti-Bad was performed to normalize) and Bim expression. Data are representative of three independent experiments with similar results. (Pidgeon et al., 2007; Giannoni et al., 2008) . In addition, it is conceivable that, in our prostate carcinoma cells, the redox-independent activity of Src kinase, which has been widely reported to be associated to carcinogenesis, is largely inadequate to sustain the survival signal, which is mainly carried out by the redoxdependent Src activity. To complete the picture of the role of redox regulation of Src in carcinogenesis, we Oxidants confer anoikis resistance to cancer cells E Giannoni et al already reported that the powerful Src oncoproteins vSrc and SrcY527F rely on their redox regulation for both the growth factor-and anchorage-independent growth (Giannoni et al., 2005) . In addition to Src kinase (Chang et al., 2008) , the Src family member Lyn has been recently correlated with prostate tumour growth (Goldenberg-Furmanov et al., 2004; Park et al., 2008) . Nevertheless, Lyn activity is unaffected by hydrogen peroxide (Mallozzi et al., 2001) , thereby suggesting that the role of Lyn in prostate cancer progression is mainly redox independent.
Oxidants confer
This study reveals that the survival of oxidative stressundergoing prostate cells, in conditions of suboptimal matrix interaction, is strongly increased and may participate in guiding these cells toward survival, thereby facilitating metastatic spread. In keeping with this hypothesis, we report herein that H 2 O 2 is able to sustain the survival of non-transformed prostate epithelial cells. This observation suggests that exposure to exogenous oxidative stress, as well as increased expression or activation of EGFR or Src kinase, may affect anoikis sensitivity of primary prostate tumour cells, thereby serving as one of the factors affecting their metastatic dissemination. Beside tumour cell-intrinsic alterations producing an oxidative stress, a growing primary tumour may undergo different pro-oxidant conditions within its microenvironment, including inflammation and hypoxia. Indeed, both pro-inflammatory and hypoxic milieu have been associated with chronic oxidative stress (Federico et al., 2007; Martinez-Sanchez and Giuliani 2007) and have now received wide interest as acknowledged traits of human invasive tumours. Hence, future studies on prostate cancers, focused on the role of both oxidative cell-autonomous mechanisms and the pro-oxidant microenvironment for metastatic dissemination, will allow new insight into the aetiology of the invasive cancer phenotype and potentially in the treatment of oxidant-sensitive metastasizing cancers.
Materials and methods
Materials
Unless specified, all reagents were obtained from Sigma (St Louis, MO, USA). All antibodies were from Cell Signalling Technology (Beverly, MA, USA), except anti-EGFR and antipTyr845EGFR antibodies, which were from Santa Cruz Biotechnology (Santa Cruz, CA, USA), the anti-Rac-1, which was from BD and the anti-ERK1/2 antibodies, which were from Upstate Biotechnology (Charlottesville, VA, USA). 2 0 ,7 0 -dichlorodihydrofluorecein diacetate was from Molecular Probes (Paisley, UK). The selective inhibitor of EGFR, and AG1478, was from Calbiochem (Nottingham, UK). PVDF was from Millipore (Billerica, MA, USA). The Annexin-V-FLUOS Staining Kit was from Roche Applied Sciences (Indianapolis, IN, USA).
Cell culture and protein overexpression
Human prostate carcinoma cells (PC3, DU145 and LNCaP) and human untransformed RWPE-1 were obtained from American Type Tissue Culture Collection. PC3 and DU145 cells were grown in Dulbecco's Modified Eagle's Medium containing 10% fetal bovine serum and antibiotics (penicillin 10 U/ml and streptomycin 10 mg/ml). LNCaP cells were cultured in RPMI-1640 added with 10% fetal bovine serum and antibiotics as above. For RWPE-1, cells were grown in Keratinocyte Serum-Free Media, containing EGF (2.5 mg), Bovine Pituitary Extract (25 mg) (GIBCO, Paisley, UK) and antibiotics (penicillin 10 U/ml and streptomycin 10 mg/ml). All cell lines were grown in 5% CO 2 -humidified atmosphere at 37 1C. For transfection experiments, PC3 cells were transiently transfected using Gene Jammer (Stratagene, La Jolla, CA, USA), as described by the manufacturer. The eukaryotic vectors pEGFP (Enhanced Green Fluorescent Protein) C-1- were serum-starved and maintained in adhesion for additional 24 h, in the presence or not of 2 mM H 2 O 2. Alternatively, RWPE-1 were serum-starved, detached and kept in suspension for 24 h with or without 2 mM H 2 O 2 . A cytofluorimetric analysis was performed to evaluate the percentage of apoptotic cells. *Po0.001 versus suspended cells ('Susp') of control cells. (b) RWPE-1 cells were treated as in panel a. An anti-pY416-Src and an anti-Src immunoblot were performed to evaluate Src activation and Src total content, respectively. EGFR tyrosine phosphorylation was evaluated by an anti-phosphotyrosine immunoblot performed on anti-EGFR immunoprecipitates. An anti-EGFR immunoblot of the immunocomplexes was performed for normalization. In addition, cell lysates were analysed by western blot to evaluate Bad phosphorylation and Bim intracellular content. Data are representative of three independent experiments with similar results.
Racwt and -RacN17 were a gift from Kozo Kaibuchi (Nagoya University, Japan). The eukaryotic expression vectors pSG5-Src wt and those encoding the redox-insensitive mutants Src C245A and Src C487A have been described earlier (Giannoni et al., 2005) . Twenty-four hours after transfection, cells were recovered for analysis.
Short Interfering RNA transfections 5-Lipoxygenase (5-LOX) siRNA and a negative control siRNA sequence were obtained from Santa Cruz Biotechnology. PC3 cells plated at 3 Â 10 5 per well in six-well dishes were transfected with 1 mg of siRNA using the siRNA Transfection Reagent (Santa Cruz Biotechnology) according to the manufacturer's protocol. The best siRNA efficiency, tested by an anti-5-LOX immunoblot, was observed 72 h after transfection.
Detachment-induced anoikis assay Serum-starved 1 Â 10 6 PC3 or RWPE-1 cells were detached with 2.5 mm EDTA, washed in phosphate-buffered saline and collected in serum-free medium. Cells were pre-suspended for 20 min and then directly seeded onto pre-coated culture dishes, treated overnight with 10 mg/ml human fibronectin or maintained in suspended conditions by plating them onto dishes pre-treated with 1 mg/ml of bovine serum albumin in culture medium, thus preventing adhesion to the dish. For the experiments using antioxidant compounds, cells were resuspended in serum-free medium containing 20 mM NAC, 10 mM nordihydroguaiaretic acid, 5 mM diphenyl-iodide, 15 mM 2-(12-hydroxydodeca-5,10-diynyl)-3,5,6-trimethyl-1,4-benzoquinone (AA861) or 5 mM rotenone and then kept in suspension for 30 min. Thereafter, treated cells were maintained in suspended conditions or left to adhere on fibronectin-coated dishes. After 24 h at 37 1C, cells were used for further analysis.
Immunoprecipitation and western blot analysis PC3 (1 Â 10 6 ) or RWPE-1 cells derived from our experimental conditions were lysed for 20 min on ice in 500 ml of RIPA lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% Triton X-100, 2 mM EGTA, 1 mM sodium orthovanadate, 1 mM phenylmethanesulphonyl-fluoride, 10 mg/ml aprotinin, 10 mg/ml leupeptin). Lysates were clarified by centrifugation and immunoprecipitated for 4 h at 4 1C with 1-2 mg of the specific antibodies. Immune complexes were collected on protein A Sepharose, separated by SDS-PAGE and transferred onto nitrocellulose. Immunoblots were incubated in 3% bovine serum albumin, 10 mM Tris/HCl pH 7.5, 1 mM EDTA and 0.1% Tween-20, for 1 h at room temperature, probed first with specific antibodies and then with secondary antibodies.
Flow cytometer analysis of apoptotic cell death Cells undergoing apoptosis were assayed by the Annexin-V-FLUOS Staining Kit (Roche Applied Sciences), according to the manufacturer's instructions. Briefly, 5 Â 10 5 PC3 or RWPE-1 cells were washed with ice-cold phosphate-buffered saline and resuspended in 100 ml of binding buffer (HEPESbuffered saline solution with 2.5 mM CaCl 2 ). Fluorescein isothiocyanate-labelled annexin V and 10 ng/ml propidium iodide (PI) were added. Cells were then incubated for 10 min in the dark at room temperature. After the addition of 400 ml of binding buffer and agitation, flow cytometry was performed using a FACSscan (BD Biosciences, San Jose, CA, USA). The analyser threshold was adjusted on the flow cytometer channel to exclude most of the subcellular debris to reduce the background noise. The totality of Annexin V þ /PI À (early apoptotic) and Annexin V þ /PI þ cells (late apoptotic) were considered apoptotic.
Detection of Src oxidation by carboxymethylation PC3 or RWPE-1 cells were cultured at 60% confluence in 10-cm dishes (1 Â 10 6 per dish) and then detached and re-plated on fibronectin-coated dishes or kept in suspension for different times. The cells were then frozen rapidly in liquid nitrogen and exposed to 0.5 ml of lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.5% [vol/vol] Triton X-100, 10 mg/ml aprotinin and 10 mg/ml leupeptin; the buffer was rendered free of oxygen by bubbling with nitrogen gas at a low flow rate for 20 min) containing 100 mM of N-(biotinoyl)-N 0 -(iodoacetyl) ethylenediamine. After sonication in a bath sonicator for three periods of 1 min each separated by 30 s intervals, cell lysates were incubated for 15 min at room temperature. Lysates were then clarified by centrifugation and 500 mg of each sample subjected to immunoprecipitation with c-Src-specific antibodies. Immunocomplexes labelled with N-(biotinoyl)-N 0 -(iodoacetyl) ethylenediamine were separated by SDS-PAGE and the biotinylated/reduced fraction of the Src kinase was revealed with Horseradish Peroxidaseconjugated streptavidin and Enhanced Chemiluminescence.
Assay of intracellular ROS Intracellular production of H 2 O 2 was assayed as described earlier (Chiarugi et al., 2003) . Three minutes before the end of each incubation time, 2 0 ,7 0 -dichlorodihydrofluorecein diacetate was added to a final concentration of 5 mM. Cells were lysed in 1 ml of RIPA buffer and analysed immediately by fluorescence analysis using a Perkin Elmer Fluorescence Spectrophotometer 650-10S equipped with a Xenon Power Supply (excitation 488 nm, emission 510 nm).
Statistical analysis
Data are presented as means±s.d. from at least three experiments. Analysis of densitometry was performed using Quantity One Software (BIORAD, Hercules, CA, USA). Results were normalized versus control expression levels. Statistical analysis of the data was performed by Student's t-test. P-valuesr0.05 were considered statistically significant. Abbreviations AA861, 2-(12-hydroxydodeca-5,10-diynyl)-3,5,6-trimethyl-1,4-benzoquinone; DCF-DA, 2 0 ,7 0 -dichlorofluorescein diacetate; ECM, extracellular matrix; EGFR, epidermal growth factor receptor; ERKs, extracellular signal-regulated protein kinases; 5-LOX, 5-Lipoxygenase; NAC, N-acetyl cisteine; PI, propidium iodide; PI3K, phosphatidylinositol 3-kinase; ROS, reactive oxygen species.
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